HUL is the safe FMCG bet that has gone nowhere. The question is whether FY27 finally moves it (NSE: HINDUNILVR)
Read More Pharma Industry News India’s CDSCO grants APAC Biotech license for immuno-oncology drug Apceden The Central Drugs Standard Control Organization (CDSCO), India’s regulatory authority, has granted a commercial license to APAC Biotech… bypharmanewsdailyApril 16, 2017
